The Supreme Court on Monday(18th Nov) directed the Delhi High Court to swiftly resolve a patent dispute involving Zydus Lifesciences’ breast cancer drug, ‘Sigrima.’ Roche alleges patent infringement, with an interim injunction restraining Zydus from selling the drug. The Court emphasized the real-world impact of judicial decisions while maintaining the injunction until a December hearing.
